🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT05898711
Active, not recruiting Observational

Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement

NCT05898711 · tracked via the Priya Life Science USA tracker
Sponsor
Kerecis Ltd.
Phase
Observational
Started
2022-01-27
Last updated
2024-12-31

Condition(s) studied

Surgery-Complications

Investigational drug(s) / intervention(s)

Fish skin graft

Fish skin graft: Kerecis Fish Skin Graft - SurgiBind

Study summary

Registry Objectives The overall objective of the registry is to collect quality and safety data to assess the long-term outcomes of Kerecis Omega3 SurgiBind in surgical procedures to reinforce soft tissue and prevent surgical complications. The ultimate goal of the registry is to enhance the quality of care, patient outcomes and establish a resource to facilitate the use of fish skin in preventing surgical wound dehiscence and surgical site infection.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Inclusion Criteria 1. Age 18 and older 2. Undergoing surgical procedure requiring soft tissue reinforcement with Kerecis Omega3 SurgiBind For example: 1. Plastic reconstructive surgery 2. Orthopedic surgery 3. Cardiothoracic surgery 4. Vascular Surgery 5. General Surgery Exclusion Criteria: <!-- --> 1. Participants who request not to be in the registry 2. Life expectancy of less than 1 year

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kerecis Arlington Virginia

More Kerecis Ltd. trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05898711 on ClinicalTrials.gov ↗ ← All trials in the USA